Works matching IS 15228517 AND DT 2020 AND VI 22 AND IP 10
Results: 21
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1419, doi. 10.1093/neuonc/noaa205
- By:
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1549, doi. 10.1093/neuonc/noaa204
- Publication type:
- Article
Opportunities for the treatment of NF1-associated low-grade gliomas: how to decide on the best treatment options for patients?
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1415, doi. 10.1093/neuonc/noaa201
- By:
- Publication type:
- Article
Mesenchymal stemlike cells in glioblastoma.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1409, doi. 10.1093/neuonc/noaa197
- By:
- Publication type:
- Article
Integrated analysis of pediatric low-grade glioma: clinical implications and the path forward.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1413, doi. 10.1093/neuonc/noaa187
- By:
- Publication type:
- Article
Marauding monocytes, macrophages, and microglia in gliomas.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1411, doi. 10.1093/neuonc/noaa185
- By:
- Publication type:
- Article
Leptomeningeal metastases: how best to assess response.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1417, doi. 10.1093/neuonc/noaa184
- By:
- Publication type:
- Article
Utility of claims data for delineation of intracranial treatment among patients with brain metastases.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1547, doi. 10.1093/neuonc/noaa175
- By:
- Publication type:
- Article
iGLASS: imaging integration into the Glioma Longitudinal Analysis Consortium.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1545, doi. 10.1093/neuonc/noaa160
- By:
- Publication type:
- Article
Emerging immunotherapies for malignant glioma: from immunogenomics to cell therapy.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1425, doi. 10.1093/neuonc/noaa154
- By:
- Publication type:
- Article
Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1422, doi. 10.1093/neuonc/noaa142
- By:
- Publication type:
- Article
Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1439, doi. 10.1093/neuonc/noaa103
- By:
- Publication type:
- Article
A combined approach of convection-enhanced delivery of peptide nanofiber reservoir to prolong local DM1 retention for diffuse intrinsic pontine glioma treatment.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1495, doi. 10.1093/neuonc/noaa101
- By:
- Publication type:
- Article
1-[(4-Nitrophenyl)sulfonyl]-4-phenylpiperazine treatment after brain irradiation preserves cognitive function in mice.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1484, doi. 10.1093/neuonc/noaa095
- By:
- Publication type:
- Article
Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomas.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1516, doi. 10.1093/neuonc/noaa094
- By:
- Publication type:
- Article
Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1474, doi. 10.1093/neuonc/noaa077
- By:
- Publication type:
- Article
Role of CX3CR1 signaling in malignant transformation of gliomas.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1463, doi. 10.1093/neuonc/noaa075
- By:
- Publication type:
- Article
Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical data.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1536, doi. 10.1093/neuonc/noaa072
- By:
- Publication type:
- Article
A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1527, doi. 10.1093/neuonc/noaa071
- By:
- Publication type:
- Article
Crosstalk between GBM cells and mesenchymal stemlike cells promotes the invasiveness of GBM through the C5a/p38/ZEB1 axis.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1452, doi. 10.1093/neuonc/noaa064
- By:
- Publication type:
- Article
A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1505, doi. 10.1093/neuonc/noaa062
- By:
- Publication type:
- Article